BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19693443)

  • 41. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis.
    Choi MR; Kim HY; Park JY; Lee TY; Baik CS; Chai YG; Jung KH; Park KS; Roh W; Kim KS; Kim SH
    Neurosci Lett; 2010 Mar; 472(2):94-8. PubMed ID: 20117176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta.
    Poloni A; Rosini V; Mondini E; Maurizi G; Mancini S; Discepoli G; Biasio S; Battaglini G; Berardinelli E; Serrani F; Leoni P
    Cytotherapy; 2008; 10(7):690-7. PubMed ID: 18985476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mesenchymal stem cells derived from human exocrine pancreas express transcription factors implicated in beta-cell development.
    Baertschiger RM; Bosco D; Morel P; Serre-Beinier V; Berney T; Buhler LH; Gonelle-Gispert C
    Pancreas; 2008 Jul; 37(1):75-84. PubMed ID: 18580448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative analysis of neuroectodermal differentiation capacity of human bone marrow stromal cells using various conversion protocols.
    Hermann A; Liebau S; Gastl R; Fickert S; Habisch HJ; Fiedler J; Schwarz J; Brenner R; Storch A
    J Neurosci Res; 2006 Jun; 83(8):1502-14. PubMed ID: 16612831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration.
    Smiler D; Soltan M; Albitar M
    Implant Dent; 2008 Sep; 17(3):236-47. PubMed ID: 18784524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells.
    Majumdar MK; Thiede MA; Mosca JD; Moorman M; Gerson SL
    J Cell Physiol; 1998 Jul; 176(1):57-66. PubMed ID: 9618145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells.
    Sorrentino A; Ferracin M; Castelli G; Biffoni M; Tomaselli G; Baiocchi M; Fatica A; Negrini M; Peschle C; Valtieri M
    Exp Hematol; 2008 Aug; 36(8):1035-46. PubMed ID: 18504067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage.
    Narita Y; Yamawaki A; Kagami H; Ueda M; Ueda Y
    Cell Tissue Res; 2008 Sep; 333(3):449-59. PubMed ID: 18607632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An efficient method for isolation of murine bone marrow mesenchymal stem cells.
    Nadri S; Soleimani M; Hosseni RH; Massumi M; Atashi A; Izadpanah R
    Int J Dev Biol; 2007; 51(8):723-9. PubMed ID: 17939119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules.
    Chen X; McClurg A; Zhou GQ; McCaigue M; Armstrong MA; Li G
    Stem Cells; 2007 Feb; 25(2):364-70. PubMed ID: 17068184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro.
    Sun Y; Chen L; Hou XG; Hou WK; Dong JJ; Sun L; Tang KX; Wang B; Song J; Li H; Wang KX
    Chin Med J (Engl); 2007 May; 120(9):771-6. PubMed ID: 17531117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells.
    Koerner J; Nesic D; Romero JD; Brehm W; Mainil-Varlet P; Grogan SP
    Stem Cells; 2006 Jun; 24(6):1613-9. PubMed ID: 16769763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft.
    Zhang J; Qi H; Wang H; Hu P; Ou L; Guo S; Li J; Che Y; Yu Y; Kong D
    Artif Organs; 2006 Dec; 30(12):898-905. PubMed ID: 17181830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis.
    Kastrinaki MC; Sidiropoulos P; Roche S; Ringe J; Lehmann S; Kritikos H; Vlahava VM; Delorme B; Eliopoulos GD; Jorgensen C; Charbord P; Häupl T; Boumpas DT; Papadaki HA
    Ann Rheum Dis; 2008 Jun; 67(6):741-9. PubMed ID: 17921184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Knockdown of p21(Cip1/Waf1) enhances proliferation, the expression of stemness markers, and osteogenic potential in human mesenchymal stem cells.
    Yew TL; Chiu FY; Tsai CC; Chen HL; Lee WP; Chen YJ; Chang MC; Hung SC
    Aging Cell; 2011 Apr; 10(2):349-61. PubMed ID: 21342417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of proteomic differential displays to assess functional discrepancies and adjustments of human bone marrow- and Wharton jelly-derived mesenchymal stem cells.
    Kuo HC; Chiu CC; Chang WC; Sheen JM; Ou CY; Kuo HC; Chen RF; Hsu TY; Chang JC; Hsaio CC; Wang FS; Huang CC; Huang HY; Yang KD
    J Proteome Res; 2011 Mar; 10(3):1305-15. PubMed ID: 21155588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of the human nucleus pulposus cell phenotype and evaluation of novel marker gene expression to define adult stem cell differentiation.
    Minogue BM; Richardson SM; Zeef LA; Freemont AJ; Hoyland JA
    Arthritis Rheum; 2010 Dec; 62(12):3695-705. PubMed ID: 20722018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunophenotype and gene expression profiles of cell surface markers of mesenchymal stem cells derived from equine bone marrow and adipose tissue.
    Ranera B; Lyahyai J; Romero A; Vázquez FJ; Remacha AR; Bernal ML; Zaragoza P; Rodellar C; Martín-Burriel I
    Vet Immunol Immunopathol; 2011 Nov; 144(1-2):147-54. PubMed ID: 21782255
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential mesengenic potential and expression of stem cell-fate modulators in mesenchymal stromal cells from human-term placenta and bone marrow.
    Jaramillo-Ferrada PA; Wolvetang EJ; Cooper-White JJ
    J Cell Physiol; 2012 Sep; 227(9):3234-42. PubMed ID: 22105866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mesenchymal stem cell isolation and characterization from human spinal ligaments.
    Asari T; Furukawa K; Tanaka S; Kudo H; Mizukami H; Ono A; Numasawa T; Kumagai G; Motomura S; Yagihashi S; Toh S
    Biochem Biophys Res Commun; 2012 Jan; 417(4):1193-9. PubMed ID: 22234304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.